NASDAQ: PASG
Passage Bio Inc Stock Ownership - Who owns Passage Bio?

Insider buying vs selling

Have Passage Bio Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Lynx1 Capital Management LP10% Owner2025-07-2466,423$5.71
$379.47kBuy
Lynx1 Capital Management LP10% Owner2025-07-2349,302$5.74
$283.04kBuy
Lynx1 Capital Management LP10% Owner2025-07-2213,123$5.44
$71.34kBuy
Orbimed Advisors LLC10% Owner2025-06-26213,257$0.33
$70.37kSell
Orbimed Advisors LLC10% Owner2025-06-25138,800$0.33
$45.80kSell
Orbimed Advisors LLC10% Owner2025-06-24231,600$0.35
$81.06kSell
Orbimed Advisors LLC10% Owner2025-04-2468,195$0.32
$21.82kSell
Orbimed Advisors LLC10% Owner2025-04-2389,328$0.34
$30.37kSell
Orbimed Advisors LLC10% Owner2025-04-2278,049$0.34
$26.54kSell
Orbimed Advisors LLC10% Owner2025-04-1777,090$0.33
$25.44kSell

1 of 4

PASG insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PASG insiders and whales buy or sell their stock.

PASG Shareholders

What type of owners hold Passage Bio Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Orbimed Advisors LLC377.94%12,013,666$91.18MInsider
Frazier Life Sciences IX LP157.59%5,009,219$38.02MInsider
Patrick J. Heron157.59%5,009,219$38.02MInsider
Thomas Woiwode156.03%4,959,769$37.64MInsider
Versant Venture Capital VI LP156.03%4,959,769$37.64MInsider
Liam Ratcliffe82.41%2,619,430$19.88MInsider
New Leaf Venture Partners LLC78.58%2,497,922$18.96MInstitution
Vanguard Group Inc64.19%2,040,564$15.49MInstitution
Renaissance Technologies LLC44.56%1,416,399$10.75MInstitution
Acadian Asset Management LLC29.38%933,764$7.09MInstitution

1 of 3

PASG vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PASG18.42%81.58%Net SellingNet Selling
ICU1.16%47.73%Net BuyingNet Buying
NNVC2.01%97.99%
FBLG8.26%14.47%Net BuyingNet Buying
CVM3.26%96.74%Net BuyingNet Buying

Passage Bio Stock Ownership FAQ

Who owns Passage Bio?

Passage Bio (NASDAQ: PASG) is owned by 263.50% institutional shareholders, 1,167.05% Passage Bio insiders, and 0.00% retail investors. Orbimed Advisors LLC is the largest individual Passage Bio shareholder, owning 12.01M shares representing 377.94% of the company. Orbimed Advisors LLC's Passage Bio shares are currently valued at $91.18M.

If you're new to stock investing, here's how to buy Passage Bio stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.